Howe & Rusling Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$10.3M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$7.62M |
| 3 |
Microsoft
MSFT
|
+$2.88M |
| 4 |
Viking Holdings
VIK
|
+$2.69M |
| 5 |
iShares Core S&P US Growth ETF
IUSG
|
+$2.66M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
+$6.51M |
| 2 |
Pinterest
PINS
|
+$5.51M |
| 3 |
Booking.com
BKNG
|
+$3.22M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.99M |
| 5 |
Broadcom
AVGO
|
+$2.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.9% |
| 2 | Financials | 10.96% |
| 3 | Healthcare | 7.28% |
| 4 | Consumer Discretionary | 7.05% |
| 5 | Industrials | 6.28% |
No holdings matched the selected filter criteria.
Similar funds
Howe & Rusling's Q1 2026 Portfolio in Review
As of Q1 2026, Howe & Rusling held 521 positions worth $1.53B, up 1.4% from $1.51B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Howe & Rusling deployed $52.3M of net new capital in Q1 2026, opening 44 new positions and adding to 162 existing holdings. Its largest new stake was AstraZeneca: 53,182 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Vanguard High Dividend Yield ETF, an estimated $6.51M trimmed.
- Howe & Rusling's largest Q1 2026 buy was AstraZeneca: 53,182 shares worth $10.5M.
- Howe & Rusling added most to Vanguard Intermediate-Term Corporate Bond ETF in Q1 2026, an estimated $7.62M increase.
- Howe & Rusling's biggest Q1 2026 reduction was Vanguard High Dividend Yield ETF, cutting an estimated $6.51M.
- Howe & Rusling fully exited Pinterest in Q1 2026, selling an estimated $5.51M.
- Howe & Rusling's ten largest holdings make up 32% of its $1.53B portfolio in Q1 2026.
- Howe & Rusling opened 44 new positions and closed 43 in Q1 2026.
- Howe & Rusling's portfolio value rose 1.4% quarter-over-quarter to $1.53B.
Based on Howe & Rusling's 13F filing for Q1 2026, filed 28 Apr 2026.